The United States Sirolimus Market is supported by demand for immunosuppressive medicines in organ transplantation and specialized disease management. Hospitals and transplant centers use established treatment protocols to help reduce the risk of organ rejection in eligible patients. Sirolimus may be included in selected treatment regimens under specialist supervision. Continued developments in...